Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Effectiveness: High, with visible results after 10-20 sessions when combined with Vitamin C
Soften and clear the inter-glandular (stroma) tissue from the sclerotic-fibrotic lesions and microbes, Release the strangulated prostatic vessels and increase blood flow
Removal Systems: Discard utilized needles, needles, and vials in assigned sharps compartments following use to forestall unintentional needle sticks
Topical formulations Serum : Most common, 1-3% GHK-Cu concentration Cream : Heavier, good for dry skin, 0.5-2% concentration Patches : Copper peptide patches deliver sustained release, convenient DIY : Some make their own from powder (advanced users) Commercial products : Many skincare brands offer GHK-Cu serums Topical application Frequency : Apply 2x daily (morning and evening) Amount : 2-3 drops serum or pea-sized amount cream Application sites : Face and neck (anti-aging) Under eyes (fine lines, dark circles) Hands (age spots, wrinkles) Any area with skin concerns Process : Cleanse skin Apply to slightly damp skin Pat gently, don't rub aggressively Let absorb (2-3 minutes) Follow with moisturizer if needed Timing : Morning application + evening application for best results Topical vs injectable for skin Topical advantages : Less expensive ($30-60 per month) No injection skill needed Direct application to target area Convenient daily use Injectable advantages : Systemic benefits (not just skin) Higher bioavailability Anti-inflammatory effects throughout body Better for deep skin layers Best approach : Combine both for maximum skin results (topical + 1mg daily injectable) Expected results timeline 4-6 weeks : Improved skin texture, slight glow 8-12 weeks : Reduced fine lines, better firmness 4-6 months : Significant wrinkle reduction, improved elasticity, even tone Long-term : Continued improvement with consistent use Realistic expectations : Not Botox-level immediate results
GLP-3 peptide is informal shorthand for a triple agonist, usually retatrutide, that activates GLP-1, GIP, and glucagon receptors
